BR9713037A - Métodos e composições para estimulação do crescimento de neurites utilizando compostos com afinidade para fkbp12 em combinação com fatores neurotróficos - Google Patents

Métodos e composições para estimulação do crescimento de neurites utilizando compostos com afinidade para fkbp12 em combinação com fatores neurotróficos

Info

Publication number
BR9713037A
BR9713037A BR9713037-0A BR9713037A BR9713037A BR 9713037 A BR9713037 A BR 9713037A BR 9713037 A BR9713037 A BR 9713037A BR 9713037 A BR9713037 A BR 9713037A
Authority
BR
Brazil
Prior art keywords
compositions
methods
fkbp12
affinity
compounds
Prior art date
Application number
BR9713037-0A
Other languages
English (en)
Inventor
Michael Su
Robert E Zelle
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25012320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9713037(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of BR9713037A publication Critical patent/BR9713037A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"Patente de Invenção: <B>"MéTODOS E COMPOSIçõES PARA ESTIMULAçãO DO CRESCIMENTO DE NEURITES UTILIZANDO COMPOSTOS COM AFINIDADE PARA FKBP12 EM COMBINAçãO COM FATORES NEUROTRóFICOS"<D>. A presente invenção refere-se a métodos e composições farmacêuticas para a estimulação do crescimento de neurites em células de nervo. As composições compreendem uma quantidade neurotrófica de um composto e um fator neurotrófico, tal como fator de crescimento de nervo (NGF). Os métodos compreendem o tratamento das células de nervo com as composições acima ou composições compreendendo o composto sem um fator neurotrófico. Os processos desta invenção podem ser utilizados para promover o reparo de lesão nervosa causada por doença ou trauma físico.
BR9713037-0A 1996-11-13 1997-11-13 Métodos e composições para estimulação do crescimento de neurites utilizando compostos com afinidade para fkbp12 em combinação com fatores neurotróficos BR9713037A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/749,114 US5780484A (en) 1996-11-13 1996-11-13 Methods for stimulating neurite growth with piperidine compounds
PCT/US1997/020868 WO1998020893A1 (en) 1996-11-13 1997-11-13 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors

Publications (1)

Publication Number Publication Date
BR9713037A true BR9713037A (pt) 2000-04-11

Family

ID=25012320

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713037-0A BR9713037A (pt) 1996-11-13 1997-11-13 Métodos e composições para estimulação do crescimento de neurites utilizando compostos com afinidade para fkbp12 em combinação com fatores neurotróficos

Country Status (19)

Country Link
US (1) US5780484A (pt)
EP (2) EP0941113A1 (pt)
JP (1) JP2001503778A (pt)
KR (1) KR100537866B1 (pt)
CN (1) CN1168443C (pt)
AR (1) AR015105A1 (pt)
AU (1) AU741186B2 (pt)
BR (1) BR9713037A (pt)
CA (1) CA2270985A1 (pt)
CO (1) CO5080733A1 (pt)
EA (1) EA003530B1 (pt)
IL (1) IL129557A0 (pt)
IN (1) IN183409B (pt)
NZ (1) NZ335396A (pt)
PL (1) PL191249B1 (pt)
TW (1) TW509572B (pt)
UA (1) UA61090C2 (pt)
WO (1) WO1998020893A1 (pt)
ZA (1) ZA9710248B (pt)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133456A (en) * 1994-08-18 2000-10-17 Ariad Gene Therapeutics, Inc. Synthetic multimerizing agents
US20030036654A1 (en) * 1994-08-18 2003-02-20 Holt Dennis A. Synthetic multimerizing agents
US6150527A (en) * 1994-08-18 2000-11-21 Ariad Pharmaceuticals, Inc. Synthetic multimerizing agents
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US6242468B1 (en) 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
ZA98825B (en) * 1997-02-27 1998-10-19 Guilford Pharm Inc Method of using neurotrophic carbamates and ureas
US6514686B2 (en) 1997-04-28 2003-02-04 The University Of British Columbia Method and composition for modulating amyloidosis
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US5968921A (en) * 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
BR9815882A (pt) 1998-06-03 2002-09-17 Gpi Nil Holding Inc Sulfonamidas ligadas por n de ácido carboxìlicos n-heterocìclicos ouou de isósteros de ácidos carboxìlicos
CN1299346A (zh) * 1998-06-03 2001-06-13 Gpi;Nil控股公司 N－杂环羧酸或羧酸等排物的脲和氨基羧酸酯
AP2001002052A0 (en) 1998-07-17 2001-03-31 Agouron Pharma Compounds, compositions, and methods for stimulating neuronal growth and elongation
GB9815880D0 (en) 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US6395758B1 (en) * 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6376517B1 (en) * 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
US7338976B1 (en) * 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
US6228872B1 (en) * 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
AU6073300A (en) 1999-07-06 2001-01-22 Vertex Pharmaceuticals Incorporated N-heterocyclic derivatives with neuronal activity
CZ200265A3 (cs) * 1999-07-09 2002-07-17 Ortho-Mcneil Pharmaceutical, Inc. Neurotrofní pyrrolidiny a piperidiny
US6734211B1 (en) 1999-07-09 2004-05-11 Oregon Health & Sciences University Compositions and methods for promoting nerve regeneration
CA2383086A1 (en) * 1999-09-08 2001-03-15 Joseph P. Steiner Non-peptidic cyclophilin binding compounds and their use
WO2001035948A2 (en) * 1999-11-12 2001-05-25 Alcon Universal Ltd. Neurophilin ligands for treating ocular conditions
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
DE60026568D1 (de) 1999-12-21 2006-05-04 Mgi Gp Inc Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
EP1360173A2 (en) 2001-01-25 2003-11-12 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
US20030203890A1 (en) * 2001-05-29 2003-10-30 Steiner Joseph P. Method for treating nerve injury caused as a result of surgery
US20040147433A1 (en) * 2001-06-14 2004-07-29 Marcus Keep Neuroimmunophilins for selective neuronal radioprotection
US6635892B2 (en) * 2002-01-24 2003-10-21 Pei Electronics, Inc. Compact integrated infrared scene projector
DE60326742D1 (de) * 2002-10-03 2009-04-30 Vertex Pharma Piperazin und piperadin-derivate für die behandlung von neurologischen krankheiten
US20060189551A1 (en) * 2004-10-04 2006-08-24 Duke University Combination therapies for fungal pathogens
ES2380779T3 (es) * 2004-12-20 2012-05-18 Wyeth Llc Análogos de rapamicina y usos de los mismos en el tratamiento de trastornos neurológicos, proliferativos e inflamatorios
CN101084226A (zh) * 2004-12-20 2007-12-05 惠氏公司 雷帕霉素衍生物及其治疗神经紊乱的用途
MX2007010076A (es) * 2005-02-17 2007-10-16 Astellas Pharma Inc Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo.
RU2008131939A (ru) * 2006-02-02 2010-02-10 Ринат Ньюросайенс Корп. (Us) Способы лечения нежелательной потери веса или нарушений приема пищи агонистами trkb
CA2637707A1 (en) * 2006-02-02 2007-08-09 Rinat Neuroscience Corporation Methods for treating obesity by administering a trkb antagonist

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
IL115685A (en) * 1994-11-16 2000-08-31 Vertex Pharma Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US5543423A (en) * 1994-11-16 1996-08-06 Vertex Pharmaceuticals, Incorporated Amino acid derivatives with improved multi-drug resistance activity
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US6037370A (en) * 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
CN104718162B (zh) * 2012-09-28 2017-11-21 Dic株式会社 α‑氧化铝微粒以及其制造方法

Also Published As

Publication number Publication date
IN183409B (pt) 1999-12-25
CA2270985A1 (en) 1998-05-22
KR100537866B1 (ko) 2005-12-21
PL191249B1 (pl) 2006-04-28
WO1998020893A1 (en) 1998-05-22
AU5439798A (en) 1998-06-03
UA61090C2 (uk) 2003-11-17
ZA9710248B (en) 1998-05-28
US5780484A (en) 1998-07-14
KR20000068964A (ko) 2000-11-25
AR015105A1 (es) 2001-04-18
PL333286A1 (en) 1999-11-22
CN1168443C (zh) 2004-09-29
AU741186B2 (en) 2001-11-22
EA003530B1 (ru) 2003-06-26
CO5080733A1 (es) 2001-09-25
EA199900463A1 (ru) 2000-02-28
IL129557A0 (en) 2000-02-29
EP0941113A1 (en) 1999-09-15
NZ335396A (en) 2000-11-24
JP2001503778A (ja) 2001-03-21
CN1239434A (zh) 1999-12-22
EP1666053A1 (en) 2006-06-07
TW509572B (en) 2002-11-11

Similar Documents

Publication Publication Date Title
BR9713037A (pt) Métodos e composições para estimulação do crescimento de neurites utilizando compostos com afinidade para fkbp12 em combinação com fatores neurotróficos
BR9712765A (pt) Processos e composições para estimulação do crescimento de neurites utilizando compostos com afinidade para fkbp12 em combinação com fatores neurotróficos
BR9712947A (pt) Processo e composições para a estimulação do crescimento de neuritos.
IL122346A0 (en) Methods and compositions for stimulating neurite growth
BR0315645A (pt) Polipetìdeos de fusão de actrib e seus usos
NO940261L (no) 5-leddete heterocykler, fremgangsmåte ved fremstilling derav og legemidler som inneholder disse forbindelser
BR9106556A (pt) Composicao farmaceutica,processo para inibir adesao intercelular mediada por selectina em um paciente,processo para tratar uma doenca inflamatoria,processo para ensaiar um composto de teste quanto a capacidade de inibir adesao celular mediada por selectina e processo para preparar um composto
BR0016150A (pt) Compostos, composições e métodos para estìmulo de crescimento e alongamento neuronal
BRPI9908914B1 (pt) composto de ferro-dextrana para uso como um componente em uma composiÇço terapÊutica, para profilaxia ou tratamento de deficiÊncia de ferro; processo para a produÇço do referido composto de ferro-dextrana e uso do referido composto para preparaÇço de uma composiÇço terapÊutica parenteralmente administrÁvel.
PT1144365E (pt) Inibidores da adesao de celulas mediada por alfa4beta1
HK1035488A1 (en) Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
AU587054B2 (en) Novel pharmaceutical compositions intended to the treatment of neuropathies and insuring the nervous regeneration
BR9713159A (pt) Composição substancialmente sólida, composto, composição de sal substancialmente sólida, mistura, e, processo para preparar um composto
BR9914441A (pt) Composição de alta pureza compreendendo (7-alfa, 17-alfa) - 17-hidroxi-7-metil-19-nor-17-pregn- 5(10)-en-20-in-3-ona, processo para preparar as composições de alta pureza, e, unidade de dosagem farmacêutica
BR9804769A (pt) Processo para tratar ou prevenir infecção por pestivìrus em um hospedeiro mamìfero tendo ou sendo suscetìvel a referida infecção,e , para tratar c~elulas de mamìferos em cultura, e, em mamìferos biológicos
BR9915431A (pt) Composição de revestimento por eletrorrevestimento catódico
BR9915803A (pt) Composição para o tratamento de neuropatia da retina ou cabeça de nervo ótico, e, processo para tratamento de neuropatia da retina ou cabeça de nervo ótico
MX9709829A (es) Metodos y composiciones para estimular el crecimiento de neurita.
GR3027661T3 (en) Treatment of tumors with neurotrophic factors and cell proliferation inhibitors.
DK1196598T3 (da) DSP-3 phosphatase med dobbelt specificitet
NO20010191L (no) Forbindelser, materialer og fremgangsmÕter for Õ stimulere neuronal vekst og elongering
ATE251640T1 (de) Neues chondrozytprotein
WO2000047243A3 (en) Pancreatic ductal trophic factors, uses and composition related thereto
BR0013547A (pt) Processo de preparação de quinoleìna-5,8-dionas
NZ334634A (en) Use of a protein extracted from mammalian liver for treating HIV

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: CONSIDERANDO QUE OS ARGUMENTOS APRESENTADOS PELA REQUERENTE NAO FORAM SATISFATORIOS, OPINO, DE ACORDO COM O ART. 37, PELO INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA (ART. 8O COMBINADO COM ART. 13 DA LPI)

B12B Appeal against refusal [chapter 12.2 patent gazette]